SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-026295
Filing Date
2024-05-15
Accepted
2024-05-15 17:16:58
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20026295_10q.htm   iXBRL 10-Q 938964
2 EXHIBIT 10.3 ef20026295_ex10-3.htm EX-10.3 171399
3 EXHIBIT 31.1 ef20026295_ex31-1.htm EX-31.1 12567
4 EXHIBIT 31.2 ef20026295_ex31-2.htm EX-31.2 12492
5 EXHIBIT 32.1 ef20026295_ex32-1.htm EX-32.1 5286
6 EXHIBIT 32.2 ef20026295_ex32-2.htm EX-32.2 5058
12 image01.jpg GRAPHIC 50158
13 image02.jpg GRAPHIC 24588
  Complete submission text file 0001140361-24-026295.txt   5167612

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240331.xsd EX-101.SCH 34649
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20240331_cal.xml EX-101.CAL 30557
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20240331_def.xml EX-101.DEF 164590
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240331_lab.xml EX-101.LAB 517326
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240331_pre.xml EX-101.PRE 299687
66 EXTRACTED XBRL INSTANCE DOCUMENT ef20026295_10q_htm.xml XML 615088
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 24952575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)